Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients
Recruiting
N/A
Interventional Study
Breast Cancer
Breast Neoplasm
Chemotherapy-Related Toxicities
Medication Adherence
Quality of Life in Cancer Patients
Accuracy of AI App
Symptom Management
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 130 (estimated)
- Sponsor
- Dena h. Al-Tameemi · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if an Arabic-language mobile application that uses artificial intelligence (AI) can help women with breast cancer during chemotherapy. The app is designed to give personalized support by reminding participants about their medications, teaching them how to manage treatment side effects, and alerting their healthcare team about serious symptoms.
The main …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Confirmed diagnosis of breast cancer stages I, II, or III.
* Patients must be currently scheduled to initiate their first-ever cycle of chemotherapy.
* Age 18 years or older.
* Ability to understand and provide informed consent.
* Possession of a smartphone (Android or iOS) an…
Contacts